Aepodia is known as a reliable partner using Best Fit Solutions for client needs, with a lean/flexible organization and processes, leading to a decrease in cycle time and costs. The company provides strong expertise and experience in the design and implementation of Early Clinical Plans, Translational Medicine Scientific Strategy, and in the execution of clinical Phase I and Phase II studies. The critical information collected during these studies, in particular, determines the probability of success for the late stage clinical development.
The results delivered by Aepodia, enable our clients to make valuable, pertinent, and rapid decisions on future development plans, based on robust, high-quality data. In addition, our innovative and specialized services include managing preferred vendors.
Optimization of Client compound development and productivity by recommending the most appropriate compound development plan (and/or study designs) with the optimal balance between: the value and pertinence of the data for a well-informed decision-making process, cycle time, quality, and costs.
Direct access to highly experienced peoplewith broad know-how on a large variety of compound types, having managed more than hundreds phase Ia/IIa trials.
A lean and flexible innovative approach in designing plans and clinical trials and managing plans to offer you three key major advantages:
Reliable data
Fast product movement
Cost-contained studies